New Key Statistics Module, Z-Score and F-Score
NAS:MRNA Key Ratios
Market Cap $ M | 41,339.51 |
Enterprise Value $ M | 33,293.16 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.98 |
Price/Sales | 6.10 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 6,754.00 |
EPS (TTM) $ | -12.41 |
Beneish M-Score | -2.62 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -135.90 |
EV-to-EBIT | -8.53 |
EV-to-EBITDA | -10.14 |
PEG | -- |
Shares Outstanding M | 382.88 |
Net Margin (%) | -69.80 |
Operating Margin % | -62.76 |
Pre-tax Margin (%) | -58.37 |
Quick Ratio | 3.36 |
Current Ratio | 3.42 |
ROA % (ttm) | -21.48 |
ROE % (ttm) | -28.66 |
ROIC % (ttm) | -41.33 |
Dividend Yield % | -- |
Altman Z-Score | 6.51 |
MRNA Number of Guru Trades
MRNA Volume of Guru Trades
Gurus Latest Trades with NAS:MRNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MRNA is held by these investors
Total 5
Moderna Inc Insider Transactions
No Available Data
News about NAS:MRNA
Total 0- 1